DeSanctis–Cacchione syndrome is a genetic disorder characterized by the skin and eye symptoms of xeroderma pigmentosum (XP) occurring in association with microcephaly, progressive intellectual disability, slowed growth and sexual development, deafness, choreoathetosis, ataxia and quadriparesis.[2]
| DeSanctis–Cacchione syndrome | |
|---|---|
| Other names | Xeroderma pigmentosum with neurologic manifestation[1] |
 | |
| DeSanctis–Cacchione syndrome is inherited in an autosomal recessive manner | |
| Specialty | Medical genetics |
Genetics
editIn at least some case, the gene lesion involves a mutation in the CSB gene.[3]
Diagnosis
editThis section is empty. You can help by adding to it. (August 2017) |
Treatment
editThis section is empty. You can help by adding to it. (August 2017) |
See also
editReferences
edit- ^ RESERVED, INSERM US14-- ALL RIGHTS. "Orphanet: De Sanctis Cacchione syndrome". www.orpha.net. Retrieved 11 October 2019.
{{cite web}}: CS1 maint: numeric names: authors list (link) - ^ Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 978-1-4160-2999-1.
- ^ Colella, S.; Nardo, T.; Botta, E.; Lehmann, A. R.; Stefanini, M. (2000). "Identical mutations in the CSB gene associated with either Cockayne syndrome or the de Sanctis-Cacchione variant of xeroderma pigmentosum". Human Molecular Genetics. 9 (8): 1171–1175. doi:10.1093/hmg/9.8.1171. PMID 10767341.
- ^ Colella S, Nardo T, Botta E, Lehmann AR, Stefanini M (May 2000). "Identical mutations in the CSB gene associated with either Cockayne syndrome or the DeSanctis-cacchione variant of xeroderma pigmentosum". Hum. Mol. Genet. 9 (8): 1171–5. doi:10.1093/hmg/9.8.1171. PMID 10767341.
External links
edit